Oxford Nanopore Technologies PLC at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone, and welcome to the 2026 JPMorgan Healthcare Conference. My name is Zain Ebrahim. I'm a European pharma and life sciences analyst here at JPMorgan. It's my great pleasure to welcome the Oxford Nanopore CEO, Gordon Sanghera; as well as the CFO, Nick Keher, who will join Dr. Sanghera for the Q&A.
So as a reminder, we'll follow the usual structure, 20 minutes presentation followed by 20 minutes Q&A, where you'll be able to ask questions either in the audience or through the web link. And with that, I'll hand over to Gordon. Thank you for being here.
Thanks, Zain. Afternoon, everybody. Okay. This has been a 20-year journey for me. We set the company up, spun out of Oxford, I was employee #1, often referred to as patient #1, still here, still going.
I am coming to the end of my tenure at the end of this quarter. But our goal 20 years ago was to develop a single
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
